Sender Gary — SEC insider filings
SEC reporting owner CIK 1659085. 29 insider filings on record with FilingPulse; latest filed 2026-10-15.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2020-08-20 to 2026-10-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 9,191 shares, $25,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 28,775 shares, $1,914,838 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 43.
- Largest priced transaction: sale of 28,775 shares @ $66.55 ($1,914,838) in Schrodinger, Inc., filed 2021-03-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Schrodinger, Inc. (SDGR) | Director | 7 | — | 1 leg · 28,775 sh · $1,914,838 | 14 |
| iBio, Inc. (IBIO) | Director | 6 | 1 leg · 9,191 sh · $25,000 | — | 5 |
| Nabriva Therapeutics plc (NBRV) | Chief Financial Officer | 8 | — | — | 10 |
| Apnimed, Inc. (APMD) | Director | 1 | — | — | 7 |
| Harmony Biosciences Holdings, Inc. (HRMY) | Director | 7 | — | — | 7 |
Insider filings — Sender Gary
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-15 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2026-08-03 | 4 | Apnimed, Inc. (APMD) | Disposition to issuer (D): 51,890 (derivative) @ $0 · Grant/award (A): 51,890 (derivative) @ $0 · Disposition to issuer (D): 44,477 (derivative) @ $0 · Grant/award (A): 44,477 (derivative) @ $0 · Grant/award (A): 44,477 (derivative) @ $0 · Disposition to issuer (D): 44,477 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-23 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 21,872 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 14,522 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | iBio, Inc. (IBIO) | Purchase (P): 9,191 @ $2.72 | EDGAR |
| 2024-11-25 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 18,900 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 8,550 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 11,657 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-05-26 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 9,613 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 14,907 (derivative) @ $0 | EDGAR |
| 2022-05-24 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 8,726 (derivative) @ $0 | EDGAR |
| 2021-12-13 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 109,000 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 8,736 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 13,333 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 15,885 @ $5.31 · Option exercise (M): 12,890 @ $17 · Sale (S): 28,775 @ $66.55 · Option exercise (M): 15,885 (derivative) @ $0 · Option exercise (M): 12,890 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Nabriva Therapeutics plc (NBRV) | Tax withholding (F): 31 @ $2.39 | EDGAR |
| 2021-02-02 | 4 | Nabriva Therapeutics plc (NBRV) | Tax withholding (F): 37 @ $2.62 | EDGAR |
| 2021-01-05 | 4 | Nabriva Therapeutics plc (NBRV) | Tax withholding (F): 32 @ $2.42 | EDGAR |
| 2020-12-01 | 4 | Nabriva Therapeutics plc (NBRV) | Tax withholding (F): 312 @ $0.43 | EDGAR |
| 2020-11-02 | 4 | Nabriva Therapeutics plc (NBRV) | Tax withholding (F): 312 @ $0.50 | EDGAR |
| 2020-10-16 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2020-10-01 | 4 | Nabriva Therapeutics plc (NBRV) | Tax withholding (F): 312 @ $0.53 | EDGAR |
| 2020-09-02 | 4 | Nabriva Therapeutics plc (NBRV) | Tax withholding (F): 312 @ $0.62 | EDGAR |
| 2020-08-21 | 4 | Nabriva Therapeutics plc (NBRV) | Option exercise (M): 11,250 · Tax withholding (F): 3,204 @ $0.65 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2020-08-20 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 16,583 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1659085 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs